The global bedless hospitals market is set to experience robust growth, with a projected value of USD 1,829.51 million by 2033, according to Future Market Insights. This growth represents a compound ...

The global antisense oligonucleotides market is poised for remarkable growth over the next decade, projected to rise from USD 2,913.5 million in 2023 to USD 5,519.6 million by 2033 moving forward with ...

The global sennosides market is poised for steady expansion over the next decade, underpinned by increasing consumer preference for natural laxatives, growing awareness about gut health, and the ...

The global therapeutic apheresis market is poised for steady growth, forecasted to reach USD 4,285.0 million by 2035, up from USD 2,922.7 million in 2025, registering a CAGR of 3.9% over the forecast ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Compound Annual Growth ...

The global 3D printed medical implants market is on a significant upward trajectory, with the market size projected to grow from USD 680.9 million in 2022 to USD 2,494.5 million by 2032, registering a ...

The global 3D printed hip and knee implants market is projected to grow significantly, reaching USD 7,953.7 million by 2035, up from USD 4,080.7 million in 2025, at a compound annual growth rate (CAGR ...

The global multiple unit pellet systems market is poised to exhibit steady growth from 2025 to 2035, expanding from USD 3,863.8 million to USD 5,294.4 million at a CAGR of 3.2%, according to recent ...

SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ...

LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ...

Net income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectivelyAdjusted EBITDA1 of $3.9 millionTotal net revenue of $18.5 million up 32% year-over-yearCompany to ...

Increase in Year-Over-Year Revenue Growth and a 44% increase in Gross profit DENVER, CO / ACCESS Newswire / May 14, 2025 / Leafbuyer Technologies Inc. ("Leafbuyer" or "the Company") (OTCQB:LBUY), a ...